Overview
Status
Active
Registry date
2017-06-23
Share capital
10,000.00 PLN
Registered address
ul. Andrzeja 19, 88-100 Inowrocław, Poland
Electronic delivery address
AE:PL-72842-21340-FEGUT-23
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2024, 23 days late).
- 202515/07/2026
- 202407/08/2025
- 202303/07/2024
- 202213/07/2023
- 202113/07/2022
- 202009/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 4.33mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -52.86kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 4.33mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 743.39kMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
Salix has been an NFZ healthcare provider since 2023. In 2026 it is performing 3 contracts with a total value of USD 717.17. All its contracts were worth USD 1.30k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | kujawsko-pomorskie | 1 | USD 636.13 |
| Pilot programmes | wielkopolskie | 1 | USD 81.04 |
| Other services provided in pharmacies | wielkopolskie | 1 | USD 0.00 |
Authorized Representatives
Beata Kmieć – President of the Management Board
Manner of representation
Independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 20 | $2,701.24 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2004-08-09.
20 1240 1066 1111 0011 5676 2422
25 1240 1037 1111 0011 5636 5072
59 1240 1037 1111 0011 5636 5333
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-12-18 | PKD change (Removed: 2 codes; Added: 6 codes) | |
| 2018-08-16 | Address change (Ul. Rynek 18, 88-150, Kruszwica → Ul. Andrzeja 19, 88-100, Inowrocław) | |
| 2017-06-23 | Entered in the register |
FAQ
The main business activity of Salix focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on June 23, 2017.
The headquarters is located at: ul. Andrzeja 19, 88-100 Inowrocław.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $4,327,841 in 2025, which is an increase of 12.8% compared to 2024.
No, the company recorded a net loss of $52,861 in 2025. For comparison, in 2024 the loss was $58,358, meaning the company reduced its loss by 9.6%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $3,344,572 in 2025, representing 77% of all operating expenses.
Last updated: 2026-10-07